諮詢報告料蘋果iPhone首季印度市場出貨量大升71%
據印度媒體《National Herald》報道,技術市場諮詢公司CMR旗下行業情報集團(IIG)發布報告,受到iPhone XR和iPhone 11系列需求帶動下,蘋果智能手機出貨量今年首季在印度市場大幅增長71%。
蘋果今年1月和2月在印度市場的iPhone出貨量按年亦增長55%以上,公司在首季度在印度的市場份額都有所增加。
據行業情報集團(IIG)負責人Prabhu Ram指iPhone XR和iPhone 11佔印度iPhone銷量達七成,其具吸引力的定價、折扣及出貨量獲得消費者青睞。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.